Skip Navigation
Skip to contents

AOCC KASID

AOCC 2020
The 8th Annual Meeting of Asian Organization for CROHN'S & COLITIS
Gateway to Excellence in IBD Research and Practice
June 18 - 20, 2020 Busan, Korea
Search

S01. AOCC Education Workshop: Tips from an expert

Room 3, December 16 (Wed), 09:00-10:30

more

Chairs Geun Am Song, Pusan National University, Korea
Tadakazu Hisamatsu, Kyorin University, Japan
09:00-09:20 Diagnosis of IBD: Clinical perspective
Ida Hilmi, University of Malaya, Malaysia
09:20-09:40 Differential diagnosis of IBD: A pathologist's advice
Jihun Kim, University of Ulsan, Korea
09:40-10:00 Role of conventional medications in the biologic era
Yue Li, Peking Union Medical College Hospital, China
10:00-10:20 Optimization of IBD therapeutics by evolving treatment goals
Miguel Regueiro, Cleveland Clinic, USA
10:20-10:30 Discussion

SS01. Treat to Target – A key piece of the IBD treatment puzzle

Room 1, December 16 (Wed), 09:30-10:30

more

Chairs Joo Sung Kim, Seoul National University, Korea
Kaichun Wu, Xijing Hospital of Digestive Diseases, Fouth Military Medical University, China
09:30-10:00 Targeting success – A tight disease control strategy in IBD
Edward V. Loftus, Jr., Mayo Clinic, USA
10:00-10:30 Evidence to support optimal IBD management in clinical practice
Taku Kobayashi, Kitasato University Kitasato Institute Hospital, Japan

SS02. Personalized CD management: Are we there yet?

Room 2, December 16 (Wed), 09:30-10:30

more

Chairs Hwang Choi, The Catholic University of Korea, Korea
Zhihua Ran, Shanghai Jiao-Tong University School of Medicine, China
09:30-10:00 Treat-to-target as a management strategy in CD
Siew Chien Ng, The Chinese University of Hong Kong, Hong Kong
10:00-10:30 How to choose and sequence CD treatment in bio-naïve patients?
Won Moon, Kosin University, Korea

S02. Current issues of IBD in Asia

Room 1, December 16 (Wed), 10:50-12:20

more

Chairs Won Ho Kim, Yonsei University, Korea
Kaichun Wu, Xijing Hospital of Digestive Diseases, Fouth Military Medical University, China
10:50-11:10 Epidemiological trends of IBD: What is new?
Siew Chien Ng, The Chinese University of Hong Kong, Hong Kong
11:10-11:30 Diagnostic challenges of IBD: How to differentiate IBD mimics?
Zhihua Ran, Shanghai Jiao-Tong University School of Medicine, China
11:30-11:50 Smart use of thiopurine and anti-TNF: What should we know?
Tadakazu Hisamatsu, Kyorin University, Japan
11:50-12:05 Abstract
12:05-12:20 Abstract

S03. New frontiers in the pathogenesis of IBD

Room 2, December 16 (Wed), 10:50-12:20

more

Chairs Mi-Na Kweon, University of Ulsan, Korea
Tae Il Kim, Yonsei University, Korea
10:50-11:10 Recent updates on genetics research and its clinical implications
Dermot P.B. McGovern, Cedars-Sinai Medical Center, USA
11:10-11:30 Crosstalk between microbiome and host immune system
Mi-Na Kweon, University of Ulsan, Korea
11:30-11:50 Mucosal immune response and novel therapeutic targets
Jae Hee Cheon, Yonsei University, Korea
11:50-12:10 Cellular and molecular mechanisms of intestinal fibrosis
Ren Mao, The First Affiliated Hospital of Sun Yat-sen University, China
12:10-12:20 Discussion

S04. Up-to-date radiological imaging in IBD

Room 3, December 16 (Wed), 10:50-12:20

more

Chairs Pin-Jin Hu, The Sixth Affiliated Hospital, Sun Yat-sen University, China
Se Hyung Kim, Seoul National University, Korea
10:50-11:10 Update on the role of CT enterography
Se Hyung Kim, Seoul National University, Korea
11:10-11:30 Current status and future directions of MR Enterography
Seong Ho Park, University of Ulsan, Korea
11:30-11:50 Ultrasonography as an emerging tool for IBD
Jiro Hata, Kawasaki Medical School, Japan
11:50-12:05 Abstract
12:05-12:20 Abstract

SS03. How to sequence advanced therapies in IBD

Room 1, December 16 (Wed), 12:20-13:20

more

Chairs Yoon Tae Jeen, Korea University, Korea
Haruhiko Ogata, Keio University, Japan
12:20-12:50 Why sequencing matters?
Katsuyoshi Matsuoka, Toho University Sakura Medical Center, Japan
12:50-13:20 Which therapy and when?
Brian L Bressler, University of British Columbia, Canada

SS04. Past, present and future of infliximab

Room 3, December 16 (Wed), 12:20-13:20

more

Chairs Won Ho Kim, Yonsei University, Korea
Yu-Fang Wang, West China Hospital, Sichuan University, China
12:20-12:50 Treatment optimization with therapeutic drug monitoring
Geom Seog Seo, Wonkwang University, Korea
12:50-13:20 Future of infliximab: Subcutaneous formulation
Byong Duk Ye, University of Ulsan, Korea

S05. Microbiome in IBD: Friends or foes?

Room 1, December 16 (Wed), 13:40-15:10

more

Chairs Dong Soo Han, Hanyang University, Korea
Zheng Qing, Renji Hospital, China
13:40-14:00 Good bugs and bad bugs in colitis and colitis-associated cancer
Christian Jobin, University of Florida, USA
14:00-14:20 Viruses and fungi in the pathogenic and therapeutic perspectives
Takayuki Imai, Shiga University of Medical Science, Japan
14:20-14:40 FMT: Where are we now and where are we going?
Young-Seok Cho, The Catholic University of Korea, Korea
14:40-15:00 The future of microbiome engineering for IBD treatment
Harry Sokol, Saint-Antoine Hospital, France
15:00-15:10 Discussion

S06. Recent advances in diagnosis and monitoring of IBD

Room 2, December 16 (Wed), 13:40-15:10

more

Chairs Hyo Jong Kim, Kyung Hee University, Korea
Akira Andoh, Shiga University of Medical Science, Japan
13:40-14:00 Optimal diagnosis in IBD: What will it change?
Silvio Danese, Humanitas Research Hospital, Italy
14:00-14:20 Emerging roles of biomarkers in IBD
Shiro Nakamura, 2nd Department of Internal Medicine, Osaka Medical College, Japan
14:20-14:40 Therapeutic drug monitoring: How, when, and for whom?
Jia-Feng Wu, National Taiwan University Hospital, Taiwan
14:40-14:55 Abstract
14:55-15:10 Abstract

S07. Looking into the operating room of IBD surgeons

Room 3, December 16 (Wed), 13:40-15:10

more

Chairs Kyu Joo Park, Seoul National University, Korea
Kil Yeon Lee, Kyung Hee University, Korea
13:40-14:00 Evolving role of IBD surgery
Willem A. Bemelman, Amsterdam University Medical Centers, Netherlands
14:00-14:20 Total proctocolectomy in UC: Tips for laparoscopic surgery
Seung-Bum Ryoo, Seoul National University, Korea
14:20-14:40 Perianal Crohn’s disease: Surgical options to save anus
Keisuke Hata, Nihonbashi-Muromachi Mitsui Tower Midtown Clinic, Japan
14:40-15:00 Experiences of IBD Surgery in the era of biologics
Kil Yeon Lee, Kyung Hee University, Korea
15:00-15:10 Discussion

S08. ECCO-AOCC Forum 2020

Room 1, December 16 (Wed), 15:30-17:00

more

Chairs Laurent Peyrin-Biroulet, Nancy University Hospital, France
Yoon Tae Jeen, Korea University, Korea
15:30-15:45 Part 1. Small bowel CD
Identification of stricture characteristic using cross sectional images: inflammatory vs fibrotic
Se Hyung Kim, Seoul National University, Korea
15:45-16:00 Part 1. Small bowel CD
Nonsurgical therapies: drugs and balloon
Takayuki Matsumoto, Iwate Medical University, Japan
16:00-16:15 Part 1. Small bowel CD
Surgical treatment: optimal timing, preparation, and technique
Willem A. Bemelman, Amsterdam University Medical Centers, Netherlands
16:15-16:30 Part 2. Acute severe UC
Optimal strategies for drug therapy: Which one, when, and how?
Hiroshi Nakase, Sapporo Medical University, Japan
16:30-16:45 Part 2. Acute severe UC
Review of outcome predictors: prognosticators and available indices
Silvio Danese, Humanitas Research Hospital, Italy
16:45-17:00 Part 2. Acute severe UC
State of the art for surgical treatment
Kyu Joo Park, Seoul National University, Korea

S09. Multidisciplinary approach in challenging cases

Room 2, December 16 (Wed), 15:30-17:00

more

Chairs Kyung Mo Kim, University of Ulsan, Korea
Young Sook Park, Eulji University, Korea
Panel discussion: Gastroenterologist, (Pediatrician (chair), Surgeon (chair))
Seong Ho Park, University of Ulsan, Korea (Radiologist)
15:30-16:00 Surgeon’s perspective for complicated CD
Yong Sik Yoon, University of Ulsan, Korea
16:00-16:30 Cutting-edge issues in Pediatric IBD
Yeoun Joo Lee, Pusan National University, Korea
16:30-17:00 Optimal management for colitis-associated rectal cancer
Su Young Kim, Yonsei University Wonju, Korea

SS05. Evolving therapeutic goals in ulcerative colitis: Important role of 5-ASA

Room 3, December 16 (Wed), 15:30-16:00

more

Chairs David Ong Eng Hui, National University Hospital Singapore, Singapore
Dong Kyung Chang, Sungkyunkwan University, Korea
15:30-16:00 Evolving therapeutic goals in ulcerative colitis: Important role of 5-ASA
Silvio Danese, Humanitas Research Hospital, Italy
16:00-16:30 Patient' survey of PENTASA® Sachet 2g in Korea: In patient's perspective of adherence and compliance
Won Moon, Kosin University, Korea

Go to Top

Hosted byThe Korean Association for the Study of Intestinal Diseases (KASID)

President: Joo-Sung Kim | Business License No.: 215-82-63277

#305, 31, Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
AOCC 2020 SecretariatP&M
3F MS Bldg., 12, Eonju-ro 79-gil, Gangnam-gu, Seoul, 06222, Korea

Privacy Policy | Terms of Use


Copyright © AOCC 2020 All Rights Reserved.